Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy A Ator

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
European Journal of Pharmacology|September 1, 2005
Comparison of the behavioral effects of bretazenil and flumazenil in triazolam-dependent and non-dependent baboonsElise M Weerts, Nancy A Ator, Barbara J Kaminski, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2013
Behavioral effects and pharmacokinetics of (±)-3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) after intragastric administration to baboonsAmy K Goodwin, Melanie Mueller, Courtney D Shell, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 16, 2011
Metabolism and disposition of 3,4-methylenedioxymethamphetamine ("ecstasy") in baboons after oral administration: comparison with humans reveals marked differencesMelanie Mueller, Amy K Goodwin, Nancy A Ator, et al.
Drug and Alcohol Dependence|November 30, 2010
Intravenous self-administration of γ-hydroxybutyrate (GHB) in baboonsAmy K Goodwin, Barbara J Kaminski, Roland R Griffiths, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 28, 2007
Morphine withdrawal dramatically reduces lymphocytes in morphine-dependent macaquesMichael R Weed, Lucy M Carruth, Robert J Adams, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 2009
Reducing abuse liability of GABAA/benzodiazepine ligands via selective partial agonist efficacy at alpha1 and alpha2/3 subtypesNancy A Ator, John R Atack, Richard J Hargreaves, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 13, 2012
GABA site agonist gaboxadol induces addiction-predicting persistent changes in ventral tegmental area dopamine neurons but is not rewarding in mice or baboonsElena Vashchinkina, Anne Panhelainen, Olga Yu Vekovischeva, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 1, 2013
Allosteric modulation of GABA(A) receptor subtypes:effects on visual recognition and visuospatial working memory in rhesus monkeys [corrected]Paul L Soto, Nancy A Ator, Sundari K Rallapalli, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 19, 2012
Long-term exposure to oral methylphenidate or dl-amphetamine mixture in peri-adolescent rhesus monkeys: effects on physiology, behavior, and dopamine system developmentPaul L Soto, Kristin M Wilcox, Yun Zhou, et al.
Journal of Psychopharmacology (Oxford, England)|June 12, 2016
Oral administration of D-alanine in monkeys robustly increases plasma and cerebrospinal fluid levels but experimental D-amino acid oxidase inhibitors had minimal effectCamilo Rojas, Jesse Alt, Nancy A Ator, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
European Journal of Pharmacology|September 1, 2005
Comparison of the behavioral effects of bretazenil and flumazenil in triazolam-dependent and non-dependent baboonsElise M Weerts, Nancy A Ator, Barbara J Kaminski, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2013
Behavioral effects and pharmacokinetics of (±)-3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) after intragastric administration to baboonsAmy K Goodwin, Melanie Mueller, Courtney D Shell, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 16, 2011
Metabolism and disposition of 3,4-methylenedioxymethamphetamine ("ecstasy") in baboons after oral administration: comparison with humans reveals marked differencesMelanie Mueller, Amy K Goodwin, Nancy A Ator, et al.
Drug and Alcohol Dependence|November 30, 2010
Intravenous self-administration of γ-hydroxybutyrate (GHB) in baboonsAmy K Goodwin, Barbara J Kaminski, Roland R Griffiths, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 28, 2007
Morphine withdrawal dramatically reduces lymphocytes in morphine-dependent macaquesMichael R Weed, Lucy M Carruth, Robert J Adams, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 2009
Reducing abuse liability of GABAA/benzodiazepine ligands via selective partial agonist efficacy at alpha1 and alpha2/3 subtypesNancy A Ator, John R Atack, Richard J Hargreaves, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 13, 2012
GABA site agonist gaboxadol induces addiction-predicting persistent changes in ventral tegmental area dopamine neurons but is not rewarding in mice or baboonsElena Vashchinkina, Anne Panhelainen, Olga Yu Vekovischeva, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 1, 2013
Allosteric modulation of GABA(A) receptor subtypes:effects on visual recognition and visuospatial working memory in rhesus monkeys [corrected]Paul L Soto, Nancy A Ator, Sundari K Rallapalli, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 19, 2012
Long-term exposure to oral methylphenidate or dl-amphetamine mixture in peri-adolescent rhesus monkeys: effects on physiology, behavior, and dopamine system developmentPaul L Soto, Kristin M Wilcox, Yun Zhou, et al.
Journal of Psychopharmacology (Oxford, England)|June 12, 2016
Oral administration of D-alanine in monkeys robustly increases plasma and cerebrospinal fluid levels but experimental D-amino acid oxidase inhibitors had minimal effectCamilo Rojas, Jesse Alt, Nancy A Ator, et al.
Pageof 3